Thomas Berger Selected Research

Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis)

11/2017	Biomarkers in the evolution of multiple sclerosis.
10/2017	Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination.
1/2017	Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases.
1/2017	Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they?
8/2013	The spectrum of MOG autoantibody-associated demyelinating diseases.
12/2011	Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders.
3/2011	Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Berger Research Topics

Disease

96	Multiple Sclerosis 11/2022 - 10/2002
21	Demyelinating Diseases (Demyelinating Disease) 11/2021 - 09/2003
14	Neuromyelitis Optica (Devic's Disease) 01/2020 - 11/2009
12	Relapsing-Remitting Multiple Sclerosis 11/2022 - 08/2012
11	Inflammation (Inflammations) 01/2022 - 02/2007
9	COVID-19 07/2022 - 01/2020
9	Disease Progression 01/2022 - 10/2005
9	Encephalitis (Encephalitis, Rasmussen) 11/2021 - 07/2008
8	Neoplasms (Cancer) 12/2021 - 03/2006
7	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 11/2017 - 03/2011
6	Ganglion Cysts (Ganglion) 10/2022 - 10/2020
6	Infections 10/2021 - 06/2004
6	Progressive Multifocal Leukoencephalopathy 01/2021 - 10/2005
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 11/2017
5	Transverse Myelitis (Necrotizing Myelitis) 01/2021 - 12/2011
5	Optic Neuritis (Retrobulbar Neuritis) 10/2020 - 12/2011
4	Autoimmune Diseases of the Nervous System 01/2022 - 10/2017
4	Central Nervous System Diseases (CNS Diseases) 01/2020 - 10/2013
3	Chronic Progressive Multiple Sclerosis 12/2021 - 08/2020
3	Seizures (Absence Seizure) 12/2021 - 11/2012
3	Myelitis 01/2021 - 05/2010
3	Nervous System Diseases (Neurological Disorders) 11/2020 - 12/2003
3	Cardiovascular Diseases (Cardiovascular Disease) 04/2020 - 01/2012
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 01/2016
3	Melanoma (Melanoma, Malignant) 04/2017 - 12/2002
3	Neuroinflammatory Diseases 11/2016 - 11/2010
3	Guillain-Barre Syndrome 10/2011 - 06/2008
2	Wounds and Injuries (Trauma) 11/2021 - 06/2004
2	Fatigue 10/2018 - 10/2015
2	Mental Disorders (Mental Disorder) 01/2018 - 01/2014
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2011 - 05/2010
2	Atrioventricular Block 09/2011 - 11/2006
2	Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome) 02/2009 - 11/2006
2	Pain (Aches) 10/2006 - 06/2005
1	Cerebral Hemorrhage 07/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Psychotic Disorders (Schizoaffective Disorder) 01/2022
1	Hallucinations (Hallucination) 12/2021
1	Rhabdomyolysis 12/2021

Drug/Important Bio-Agent (IBA)

36	AntibodiesIBA 01/2022 - 07/2003
23	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2006
19	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021 - 10/2002
14	Natalizumab (Tysabri)FDA Link 11/2022 - 10/2005
12	AutoantibodiesIBA 01/2021 - 12/2003
11	Retinaldehyde (Retinal)IBA 10/2022 - 03/2014
9	Immunoglobulin G (IgG)IBA 01/2021 - 06/2008
8	Fingolimod Hydrochloride (FTY720)FDA Link 01/2021 - 08/2012
7	Complement System Proteins (Complement)IBA 11/2021 - 09/2003
5	VaccinesIBA 01/2022 - 04/2017
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2003
5	Rituximab (Mabthera)FDA Link 01/2021 - 05/2013
4	Monoclonal AntibodiesIBA 07/2022 - 06/2003
4	Alemtuzumab (Campath)FDA Link 07/2022 - 01/2017
4	nitazoxanide (NTZ)FDA Link 12/2021 - 11/2019
4	IronIBA 12/2021 - 01/2017
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 01/2015
4	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 12/2009
4	Interferon-betaIBA 03/2019 - 12/2009
4	EpitopesIBA 10/2013 - 06/2003
3	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 01/2020
3	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 11/2009
3	Pharmaceutical PreparationsIBA 08/2020 - 08/2012
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 05/2012
3	AutoantigensIBA 01/2017 - 01/2007
3	AntigensIBA 06/2008 - 06/2003
2	InterferonsIBA 01/2021 - 01/2018
2	SteroidsIBA 01/2021 - 01/2019
2	ocrelizumabIBA 01/2021 - 08/2020
2	Protein Isoforms (Isoforms)IBA 01/2021 - 05/2010
2	TabletsIBA 11/2020 - 01/2013
2	teriflunomideIBA 11/2020 - 07/2019
2	Dimethyl FumarateIBA 10/2019 - 07/2019
2	ChemokinesIBA 04/2019 - 07/2008
2	Biological ProductsIBA 12/2017 - 01/2010
2	Oligoclonal BandsIBA 08/2017 - 12/2015
2	Peptides (Polypeptides)IBA 04/2017 - 10/2015
2	Aquaporins (Water Channels)IBA 01/2016 - 12/2011
2	4-Aminopyridine (4 Aminopyridine)FDA Link 01/2013 - 11/2012
2	Immunoglobulin M (IgM)IBA 07/2008 - 12/2003
2	Therapeutic UsesIBA 08/2007 - 11/2006
2	CannabinoidsIBA 10/2006 - 06/2005
2	Myelin Basic ProteinIBA 07/2003 - 10/2002
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 12/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2021

Therapy/Procedure

33	Therapeutics 01/2022 - 10/2003
5	Radiotherapy 12/2021 - 04/2011
4	Cardiac Rehabilitation 01/2021 - 12/2012
4	Proton Therapy 01/2021 - 10/2012
3	Aftercare (After-Treatment) 01/2022 - 01/2018
3	Secondary Prevention 04/2020 - 07/2011
2	Immunotherapy 01/2022 - 01/2021
2	Radiofrequency Ablation 01/2013 - 09/2011
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2012 - 10/2010
2	Catheter Ablation 02/2009 - 11/2006
2	Catheters 11/2006 - 06/2004
1	Premedication 07/2022
1	Immunomodulation 01/2022